AbstractVaccination of immunocompromised patients is challenging both regarding efficacy and safety. True efficacy data are lacking so existing recommendations are based on immune responses and safety data. Inactivated vaccines can generally be used without risk but the patients who are most at risk for infectious morbidity and mortality as a result of their severely immunosuppressed state are also those least likely to respond to vaccination. However, vaccination against pneumococci, Haemophilus influenzae and influenza are generally recommended. Live vaccines must be used with care because the risk for vaccine-associated disease exists
Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at incr...
Background Immunocompromised patients are vulnerable to severe or complicated influenza infection. V...
Many national guidelines recommend annual influenza vaccination of immunocompromised patients, al-th...
AbstractVaccination of immunocompromised patients is challenging both regarding efficacy and safety....
In immunocompromised individuals the incidence and severity of vaccine-preventable diseases is part...
Vaccination is crucial for avoiding infection-associated morbidity and mortality among immunocomprom...
Infection prevention is a key component of care and an important determinant of clinical outcomes in...
Central to this thesis is the immunocompromised patient (ICPs) and infection prevention by vaccinati...
Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunoco...
BackgroundImmunocompromised (IC) individuals are at higher risk for severe complications of influenz...
Vaccination of immunocompromised patients is recommended in many national guidelines to protect agai...
Vaccination of immunocompromised patients is recommended in many national guidelines to protect agai...
Live vaccines are generally contraindicated on immunosuppressive therapy due to safety concerns. How...
BACKGROUND: Available data show that COVID-19 vaccines may be less effective in immunocompromised po...
Immunocompromised patients are vulnerable to severe or complicated influenza infection. Vaccination ...
Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at incr...
Background Immunocompromised patients are vulnerable to severe or complicated influenza infection. V...
Many national guidelines recommend annual influenza vaccination of immunocompromised patients, al-th...
AbstractVaccination of immunocompromised patients is challenging both regarding efficacy and safety....
In immunocompromised individuals the incidence and severity of vaccine-preventable diseases is part...
Vaccination is crucial for avoiding infection-associated morbidity and mortality among immunocomprom...
Infection prevention is a key component of care and an important determinant of clinical outcomes in...
Central to this thesis is the immunocompromised patient (ICPs) and infection prevention by vaccinati...
Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunoco...
BackgroundImmunocompromised (IC) individuals are at higher risk for severe complications of influenz...
Vaccination of immunocompromised patients is recommended in many national guidelines to protect agai...
Vaccination of immunocompromised patients is recommended in many national guidelines to protect agai...
Live vaccines are generally contraindicated on immunosuppressive therapy due to safety concerns. How...
BACKGROUND: Available data show that COVID-19 vaccines may be less effective in immunocompromised po...
Immunocompromised patients are vulnerable to severe or complicated influenza infection. Vaccination ...
Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at incr...
Background Immunocompromised patients are vulnerable to severe or complicated influenza infection. V...
Many national guidelines recommend annual influenza vaccination of immunocompromised patients, al-th...